biolab shop bpc 157 BPC-157 + TB-500 Blend 5/5mg BPC-157 Peptide Supplier | Atlas

Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes

thanks Gachon University for funding

Because these medicines are not yet licensed, there are no approved patient information leaflets or UK Summary of Product Characteristics (SmPC) available

At ICC, we stay focused on whats emerging so care decisions are informed, not reactive